North America Pharmaceutical Cro Market Size & Outlook
North America pharmaceutical cro market, 2018-2030 (US$M)
Related Markets
North America pharmaceutical cro market highlights
- The North America pharmaceutical cro market generated a revenue of USD 9,897.5 million in 2024.
- The market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating type in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 9,897.5 million |
| Market revenue in 2030 | USD 13,728.7 million |
| Growth rate | 5.6% (CAGR from 2024 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, North America region accounted for 24.0% of the global pharmaceutical cro market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 32,105.5 million by 2030.
Clinical was the largest segment with a revenue share of 75.57% in 2024. Horizon Databook has segmented the North America pharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
In 2024, North America accounts for 24.01% of the global pharmaceutical CRO market, owing to growing investments in pharmaceutical companies' new drug formulations. The growth of the pharmaceutical industry in the U.S. and Canada is a key factor contributing to market growth.
In addition, the presence of established market players and an increasing number of clinical trials are anticipated to drive market growth. Besides, stringent regulatory requirements, particularly in the U.S., Canada & Mexico, necessitate specialized knowledge expertise, making CROs an attractive option for navigating regulatory scenarios.
Furthermore, increasing mergers & acquisitions among CROs to expand service offerings, geographic presence, and capabilities is expected to drive the North America pharmaceutical CRO market. For instance, in November 2023, CEBIS International, a global Contract Research Organization (CRO) announced its expansion into the North American market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical CRO Market Scope
Pharmaceutical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America pharmaceutical cro market size, by country, 2018-2030 (US$M)
North America Pharmaceutical CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
